Merck primes the market for its biosims with online effort targeting docs, patients

Merck & Co.’s ($MRK) U.S. biosimilars are still in the clinic–but the pharma giant wants to prepare the ground for their arrival. That’s the idea behind …

from Online Marketing http://ift.tt/2etIlOe via Online Marketing

from Tumblr http://ift.tt/2doJAkm